Carotid artery stenting: what have we learned from the clinical trials and registries and where do we go from here?

Philip P Goodney; Richard J Powell

doi:10.1016/j.avsg.2007.10.002

Carotid artery stenting: what have we learned from the clinical trials and registries and where do we go from here?

Ann Vasc Surg. 2008 Jan;22(1):148-58. doi: 10.1016/j.avsg.2007.10.002.

Authors

Philip P Goodney¹, Richard J Powell

Affiliation

¹ Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.

PMID: 18082918
DOI: 10.1016/j.avsg.2007.10.002

Abstract

As with other minimally invasive surgical procedures, carotid angioplasty and stenting (CAS) has developed rapidly over the last decade. Although many believe equivalency with carotid endarterectomy has been established in high-risk patients, the effectiveness of CAS in lower-risk patients is not yet established. This report aims to provide a comprehensive and critical review of the trials and registries of CAS and to offer insight into future directions of this emerging technology.

Publication types

Review

MeSH terms

Angioplasty / adverse effects
Angioplasty / economics
Angioplasty / instrumentation*
Carotid Stenosis / mortality
Carotid Stenosis / surgery*
Data Interpretation, Statistical
Endarterectomy, Carotid* / adverse effects
Evidence-Based Medicine
Humans
Insurance, Health, Reimbursement
Patient Selection
Practice Guidelines as Topic
Randomized Controlled Trials as Topic*
Registries*
Research Design
Stents* / economics
Stroke / etiology
Treatment Outcome
United States